Antengene Set to Showcase Innovative Preclinical Findings on ATG-201 at the Upcoming ACR 2025 Conference Antengene Corporation will unveil groundbreaking preclinical data on ATG-201 at ACR 2025, advancing treatment options for autoimmune diseases.

Antengene Set to Showcase Innovative Preclinical Findings on ATG-201 at the Upcoming ACR 2025 Conference #United_States #Chicago #Antengene #ATG-201 #CD19xCD3